You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 8,501,174

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,501,174

Title:	Prevention and treatment of ocular side effects with a cyclosporin
Abstract:	Therapeutic methods are disclosed herein.
Inventor(s):	Feinerman; Gregg (Irvine, CA), Barth; Neil (Newport Beach, CA), Schiffman; Rhett M. (Laguna Beach, CA), Barnett; Pamela S. (Aliso Viejo, CA)
Assignee:	Allergan, Inc. (Irvine, CA)
Application Number:	12/825,116
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,501,174
Patent Claims:	1. A method comprising administering cyclosporin A to an eye of a mammal in combination with administration of rituximab, wherein said method is effective in treating abnormal lacrimation, keratitis, or conjunctivitis. 2. The method of claim 1 wherein said method is effective in treating abnormal lacrimation. 3. The method of claim 1 wherein said method is effective in treating keratitis. 4. The method of claim 1 wherein said method is effective in treating conjunctivitis.

Details for Patent 8,501,174

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	RITUXAN	rituximab	Injection	103705	11/26/1997	⤷ Try a Trial	2025-10-14
Idec Pharmaceuticals Corp.	RITUXAN	rituximab	Injection	103737	02/19/2002	⤷ Try a Trial	2025-10-14
Genentech, Inc.	RITUXAN HYCELA	rituximab and hyaluronidase human	Injection	761064	06/22/2017	⤷ Try a Trial	2025-10-14
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.